221121-37-5

Basic information

• Product Name: 4-(4-FLUORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER
• Synonyms: 4-(4-FLUORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER;4-(4-Fluorophenyl)-3-oxobutanoic acid ethyl ester
• CAS NO: 221121-37-5
• Molecular Formula: C₁₂H₁₃FO₃
• Molecular Weight: 224.23
• Mol File: 221121-37-5.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 295.509 °C at 760 mmHg
• Flash Point: 128.353 °C
• Appearance: /
• Density: 1.161 g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.493
• PKA: 10.35±0.46(Predicted)
• CAS DataBase Reference: 4-(4-FLUORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-FLUORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER(221121-37-5)
• EPA Substance Registry System: 4-(4-FLUORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER(221121-37-5)

Safety Data

• Hazardous Substances Data: 221121-37-5(Hazardous Substances Data)

Usage

Uses

Ethyl 4-(4-Fluorophenyl)-3-oxobutanoate is used in the synthesis of novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors with high potency against NNRTI-resistant HIV-1 strains. Also used in the structural evaluation of 2-substituted 5-hydroxyindole 3-carboxylates as potent inhibitors of human 5-lipoxygenase.

InChI:InChI=1/C12H13FO3/c1-2-16-12(15)8-11(14)7-9-3-5-10(13)6-4-9/h3-6H,2,7-8H2,1H3

Upstream product

• 64-17-5 ethanol 
• 1035695-10-3 5-[2-(4-fluorophenyl)-1-hydroxyethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 42201-84-3 1-ethoxy-1-(tert-butyldimethylsilyloxy)ethene 
• 587-88-2 ethyl 2-(4-fluorophenyl)acetate 
• 623-73-4 diazoacetic acid ethyl ester 
• 18511-62-1 4-fluorostyrene oxide 
• 459-04-1 4-Fluorophenylacetyl chloride 
• 2033-24-1 cycl-isopropylidene malonate 
• 405-50-5 p-Fluorophenylacetic acid 
• 6148-64-7 ethyl potassium malonate 
• 221121-30-8 2-(4-fluorophenyl)-1-(1H-imidazol-1-yl)ethan-1-one 

Downstream Products

• 1052114-80-3 ethyl 5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxylate 
• 1449300-94-0 1-[2-(dimethylamino)-2-oxoethyl]-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid 
• 1052114-81-4 5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridin-3-ylcarboxylic acid 
• 1449299-72-2 N-{4-[2-amino-5-(3,4-dimethoxyphenyl)pyridin-3-yl]phenyl}-5-(4-fluorophenyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydropyridine-3-carboxamide 
• 1449300-86-0 5-(4-fluorophenyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydropyridine-3-carboxylic acid 
• 1449300-84-8 ethyl 5-(4-fluorophenyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydropyridine-3-carboxylate 
• 1449299-65-3 N-{4-[2-amino-5-(3,4-dimethoxyphenyl)pyridin-3-yl]phenyl}-5-(4-fluorophenyl)-4-oxo-1-(propan-2-yl)-1,4-dihydropyridine-3-carboxamide 
• 1449300-67-7 N-{4-[2-amino-5-(3-hydroxy-4-methoxyphenyl)pyridin-3-yl]phenyl}-5-(4-fluorophenyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydropyridine-3-carboxamide 
• 1449300-79-1 5-(4-fluorophenyl)-4-oxo-1-(propan-2-yl)-1,4-dihydropyridine-3-carboxylic acid 
• 1449300-61-1 N-[4-(2-amino-4-methoxypyridin-3-yl)phenyl]-5-(4-fluorophenyl)-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydropyridine-3-carboxamide 
• 1449300-78-0 5-(4-fluorophenyl)-1-isopropyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid ethyl ester 
• 1449299-63-1 N-{4-[2-amino-5-(3,4-dimethoxyphenyl)pyridin-3-yl]phenyl}-1-ethyl-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide 

Relevant articles and documents

Non-metal Lewis acid-catalyzed cross-Claisen condensation for β-keto esters

In this work, we disclose a new catalytic and highly chemoselective cross-Claisen condensation of esters. In the presence of TBSNTf2 as a non-metal Lewis acid, various esters can undergo cross-Claisen condensation to form β-keto esters which are important building blocks. Compared with the traditional Claisen condensation, this process, employing silyl ketene acetals (SKAs) as carbonic nucleophiles to achieve cross-Claisen condensation, requires mild conditions and has good tolerance of functional groups. This journal is

Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation

Axl has emerged as an attractive target for cancer therapy due to its strong correlation with tumor growth, metastasis, poor survival, and drug resistance. Herein, we report the design, synthesis and structure-activity relationship (SAR) investigation of a series of pyrrolo[2,3-d]pyrimidine derivatives as new Axl inhibitors. Among them, the most promising compound 13b showed high enzymatic and cellular Axl potencies. Furthermore, 13b possessed preferable pharmacokinetic properties and displayed promising therapeutic effect in BaF3/TEL-Axl xenograft tumor model. Compound 13b may serve as a lead compound for new antitumor drug discovery.

MACROCYCLIC FUSED PYRRAZOLES AS MCL-1 INHIBITORS

Provided are compounds represented by Formula IA: (IA), and the pharmaceutically acceptable salts and solvates thereof, wherein R, R 1a, R 1b, L 1, L 2, L 3, X, A, B and C are as defined as set forth